Medley: Q2 FY2026 sales rose 21% YoY, profit more than doubled, and dividends will be initiated

Sales and profit grew strongly in Q2 FY2026, with both HR PF and Medical PF segments contributing to a 21% YoY sales increase and a 116% rise in profit attributable to owners. EBITDA margin improved to 26%, and the company is on track to exceed full-year profit forecasts, initiating dividends for the first time.

Original document: Medley, Inc. [4480] Slides Release — Aug. 13 2026